Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-14

Clinical Trial Update: Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating micafungin for prevention of invasive fungal disease in pediatric and adolescent patients undergoing autologous hema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Neutropenia, Fungal Disease | Phase 2 | Status: UNKNOWN